Zheng Meng

Zheng Meng

Company: Ultragenyx Pharmaceutical

Job title: Senior Director - Analytical Development

Seminars:

Analytical Characterization of mRNA Replacement Therapy for Rare Genetic Disease 9:00 am

Potential critical quality attributes for mRNA replacement therapy Examples of mRNA potency analysis Safety related impurity controlRead more

day: Day Two

Panel Discussion – Benchmarking Regulatory Harmonization for State-of-the-Art Analytical Methods, Qualification, and Validation 9:40 am

With the expansion of mRNA-therapeutic applications at an accelerated pace, there is now a greater necessity to characterize mRNA to better understand their mechanisms of action and the performance systems. Novel analytical approaches, specifically within production, purification and high throughput automation needs to be developed to address design, test and analyse such systems. Validation of…Read more

day: Day Two

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.